Antimicrobial-resistant pathogens associated with healthcare- associated infections: Summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2009-2010

Infection Control and Hospital Epidemiology

Volumn 34, Issue 1, 2013, Pages 1-14

  Sievert, Dawn M ^a   Ricks, Philip ^a   Edwards, Jonathan R ^a   Schneider, Amy ^a   Patel, Jean ^a   Srinivasan, Arjun ^a   Kallen, Alex ^a   Limbago, Brandi ^a   Fridkin, Scott ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MOXIFLOXACIN; OXACILLIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TOBRAMYCIN; VANCOMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CANDIDA; CATHETER INFECTION; CEPHALOSPORIN RESISTANT KLEBSIELLA OXYTOCA; CEPHALOSPORIN RESISTANT KLEBSIELLA PNEUMONIAE; CHILD; COAGULASE NEGATIVE STAPHYLOCOCCUS; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; HOSPITAL INFECTION; HUMAN; INFANT; INFORMATION PROCESSING; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEWBORN; NONHUMAN; PRESCHOOL CHILD; PSEUDOMONAS AERUGINOSA; PUBLIC HEALTH SERVICE; SCHOOL CHILD; STAPHYLOCOCCUS AUREUS; URINARY TRACT INFECTION; VANCOMYCIN RESISTANT ENTEROCOCCUS; VENTILATOR ASSOCIATED PNEUMONIA;

BACTEREMIA; CANDIDA; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; ENTEROCOCCUS; GRAM-NEGATIVE BACTERIA; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PHENOTYPE; PNEUMONIA, VENTILATOR-ASSOCIATED; PREVALENCE; REGRESSION ANALYSIS; SURGICAL WOUND INFECTION; UNITED STATES; URINARY TRACT INFECTIONS;

EID: 84870946642     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/668770     Document Type: Article

References (11)

1. Hidron AI, Edwards JR, Patel J, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008; 29(11): 996-1011, Erratum in Infect Control Hosp Epidemiol 2009;30(1): 107.
2. CDC. The National Healthcare Safety Network (NHSN) Manual. Patient Safety Component Protocol. Centers for Disease Control and Prevention website. http://www.cdc.gov/ncidod /dhqp/pdf/nhsn/NHSN_Manual_PatientSafetyProtocol_CURRENT.pdf. Published 2008.
3. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing-sixteenth informational supplement. Wayne, PA: CLSI, 2008. CLSI document M100-S18.
4. Magiorakos A-P, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard def- initions for acquired resistance. Clin Microbiol Infect 2012;18(3): 268-281.
5. Landrum ML, Neumann C, Cook C, et al. Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005-2010. JAMA 2012;308(1): 50-59.
6. Kallen AJ, Mu Y, Bulens S, et al; Health care-associated invasive MRSA infections, 2005-2008. JAMA 2010;304(6):641-648.
7. Kallen AJ, Hidron AI, Patel J, Srinivasan A. Multidrug resistance among gram-negative pathogens that caused healthcare-asso- ciated infections reported to the National Healthcare Safety Net- work, 2006-2008. Infect Control Hosp Epidemiol 2010;31(5): 528-531.
8. Bradley JS, Guidos R, Baragona S, et al. Anti-infective research and development: problems, challenges, and solutions. Lancet 2007;7:68-78.
9. Lewis JS II, Herrera M, Wickes B, Patterson JE, Jorgensen JH. First report of the emergence of CTX-M-type extended-spectrum b-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrob Agents Chemother 2007; 51:4015-4021.
10. Bradford PA, Bratu S, Urban C, et al. Emergence of carbapenem- resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 b-lacta- mases in New York City. Clin Infect Dis 2004;39:55-60.
11. Sexton DJ, Chen LF, Anderson DJ. Current definitions of central line-associated bloodstream infection: is the emperor wearing clothes? Infect Control Hosp Epidemiol 2010;31(12):1286-1289.